ABM Respiratory Care Raises $10.3M in Series A Funding Round: Company to Advance Commercialization in the US

October 27, 2020

ABM Respiratory Care, a medical device company focused on developing novel integrated airway clearance and ventilation solutions, announced today the raise of US$10.3M in its series A funding round led by Advanced MedTech Holdings, a global medical technology leader, and SEEDS Capital, the investment arm of Enterprise Singapore. The funding will help ABM advance their US commercialization plans.

ABM Respiratory Care also announced the appointment of Peter H. Soderberg as Chairman of the company’s Board of Directors. Mr. Soderberg currently serves as the Chairman of the Board of Directors for Tactile Medical, a publicly-traded medical device company. Mr. Soderberg recently concluded 18 years of service on the board of directors of Integer Holdings Corp. (formerly Greatbatch, Inc.), a medical technology company. Mr. Soderberg previously served on the boards of Constellation Brands, Inc. and the Advanced Medical Technology Association.

In addition, Mr. Soderberg is currently the Managing Partner of Worthy Venture Resources, LLC, a company focused on growing commercial-stage companies to a global market presence. Before his semi-retirement in 2010, he served as President and Chief Executive Officer of Hillenbrand Industries and Hill-Rom, and, before that, of Welch Allyn. He has previously held executive positions at Johnson and Johnson in a variety of operations, marketing, and management roles, including President of Johnson & Johnson Health Management.

“We are delighted to have Mr. Soderberg join ABM as chairman of our board of directors,” Vinay Joshi, CEO of ABM Respiratory Care, commented, “His appointment comes at a great time for the company since we recently completed our Series A funding of US$10.3 million, secured a significant order for our Alpha ventilator, and received 510(k) clearance by the US FDA for our BiWaze™ Airway Clearance System earlier this year. Mr. Soderberg is a seasoned medical industry leader who has decades of experience leading successful medical device companies. ABM Respiratory Care will leverage his experience as we execute our corporate strategy.”

“I welcome the opportunity to join ABM Respiratory Care as the Chairman of the Board of Directors,” Mr. Soderberg said. “I’m excited to work with ABM to advance the standard of care in treating chronic and acute respiratory diseases and conditions with their innovative solutions, particularly as they now seek to rapidly establish their U.S. presence.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version